Market Cap 331.55M
Revenue (ttm) 14.20M
Net Income (ttm) -49.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -349.23%
Debt to Equity Ratio 0.00
Volume 847,000
Avg Vol 1,041,312
Day's Range N/A - N/A
Shares Out 71.15M
Stochastic %K 6%
Beta 0.45
Analysts Strong Sell
Price Target $9.54

Company Profile

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs). It develops OPGx-LCA5, an early-onset retinal degeneration that is in Phase 1/2 clinical trial for the treatment of LCA5-associated IRD; and OPGx-BEST1 to treat BEST1-associated retinal disease. The company also develops various pre-clinical IRD programs, including OPGx-RHO, a gene therapy that targets autosomal do...

Industry: Biotechnology
Sector: Healthcare
Phone: 984 884 6030
Website: opusgtx.com
Address:
8 Davis Drive, Suite 220, Durham, United States
QuantInsider
QuantInsider Mar. 20 at 7:50 PM
$IRD taking a beating lately, down 4.7% today and 10.6% over the past week No fresh news, just pure sell-off action Options activity is all about those same-day deep ITM $2.5 calls with 500 contracts but nothing screams big moves Looks more like hedging than a real upside play If you're thinking of jumping in, keep it tight with risk limits This one's all about riding the volatility wave for now
0 · Reply
ifinitis
ifinitis Mar. 18 at 8:16 PM
$IRD Weak Hands taking profits..and.. Wall Street dropping to get in before it runs up! IMO. To be expected in hind site!
0 · Reply
TruthTooPower
TruthTooPower Mar. 18 at 5:45 PM
$IRD!!! Rock On Adding!!!
0 · Reply
McLarkin
McLarkin Mar. 17 at 3:48 PM
$OCGN well well - folks seem to notice these now, not quite another $IRD but certainly going for it in Retinal Gene Therapy - which feels one of the lowest risk and better probabilities of Gene Therapy Success...
0 · Reply
Atime2Buy
Atime2Buy Mar. 17 at 2:21 PM
$IRD people cant hold to save their @ss. this dip seems to be based solely on profit taking, good time to buy.
0 · Reply
ifinitis
ifinitis Mar. 16 at 9:05 PM
$IRD Looks good on saying good bye to $5.20 tomorrow! Oppenheimer initiated coverage with an outperform rating and a price target of $10.00.
0 · Reply
erevnon
erevnon Mar. 16 at 3:56 PM
Oppenheimer initiates coverage on Opus Genetics $IRD at Outperform rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:47 PM
$IRD 10:22 on Mar. 16 2026 Oppenheimer Initiates Coverage On Opus Genetics with Outperform Rating, Announces Price Target of $10 #tradeideas
1 · Reply
Um8a123
Um8a123 Mar. 16 at 1:03 PM
$IRD Ready for next leg, $6:35
0 · Reply
erevnon
erevnon Mar. 12 at 3:01 PM
Wedbush maintains Opus Genetics $IRD at Outperform and raises the price target from $8 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Latest News on IRD
Opus Genetics: Asymmetric Upside With LCA5 And BEST1

Feb 22, 2026, 9:35 PM EST - 26 days ago

Opus Genetics: Asymmetric Upside With LCA5 And BEST1


Opus Genetics Announces $25 Million Private Placement

Feb 13, 2026, 7:30 AM EST - 5 weeks ago

Opus Genetics Announces $25 Million Private Placement


Opus Genetics to Participate in Upcoming Investment Conferences

Nov 20, 2025, 8:00 AM EST - 4 months ago

Opus Genetics to Participate in Upcoming Investment Conferences


Opus Genetics Announces $23 Million Registered Direct Offering

Nov 6, 2025, 7:00 AM EST - 4 months ago

Opus Genetics Announces $23 Million Registered Direct Offering


Opus Genetics, Inc. - Special Call

Sep 30, 2025, 12:12 PM EDT - 6 months ago

Opus Genetics, Inc. - Special Call


Opus Genetics Appoints Rob Gagnon as Chief Financial Officer

Sep 2, 2025, 8:00 AM EDT - 7 months ago

Opus Genetics Appoints Rob Gagnon as Chief Financial Officer


Opus Genetics Announces Financial Results for Full Year 2024

Mar 31, 2025, 8:20 AM EDT - 1 year ago

Opus Genetics Announces Financial Results for Full Year 2024


Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program

Feb 18, 2025, 7:30 AM EST - 1 year ago

Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program


QuantInsider
QuantInsider Mar. 20 at 7:50 PM
$IRD taking a beating lately, down 4.7% today and 10.6% over the past week No fresh news, just pure sell-off action Options activity is all about those same-day deep ITM $2.5 calls with 500 contracts but nothing screams big moves Looks more like hedging than a real upside play If you're thinking of jumping in, keep it tight with risk limits This one's all about riding the volatility wave for now
0 · Reply
ifinitis
ifinitis Mar. 18 at 8:16 PM
$IRD Weak Hands taking profits..and.. Wall Street dropping to get in before it runs up! IMO. To be expected in hind site!
0 · Reply
TruthTooPower
TruthTooPower Mar. 18 at 5:45 PM
$IRD!!! Rock On Adding!!!
0 · Reply
McLarkin
McLarkin Mar. 17 at 3:48 PM
$OCGN well well - folks seem to notice these now, not quite another $IRD but certainly going for it in Retinal Gene Therapy - which feels one of the lowest risk and better probabilities of Gene Therapy Success...
0 · Reply
Atime2Buy
Atime2Buy Mar. 17 at 2:21 PM
$IRD people cant hold to save their @ss. this dip seems to be based solely on profit taking, good time to buy.
0 · Reply
ifinitis
ifinitis Mar. 16 at 9:05 PM
$IRD Looks good on saying good bye to $5.20 tomorrow! Oppenheimer initiated coverage with an outperform rating and a price target of $10.00.
0 · Reply
erevnon
erevnon Mar. 16 at 3:56 PM
Oppenheimer initiates coverage on Opus Genetics $IRD at Outperform rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:47 PM
$IRD 10:22 on Mar. 16 2026 Oppenheimer Initiates Coverage On Opus Genetics with Outperform Rating, Announces Price Target of $10 #tradeideas
1 · Reply
Um8a123
Um8a123 Mar. 16 at 1:03 PM
$IRD Ready for next leg, $6:35
0 · Reply
erevnon
erevnon Mar. 12 at 3:01 PM
Wedbush maintains Opus Genetics $IRD at Outperform and raises the price target from $8 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Tazdoc88
Tazdoc88 Mar. 12 at 2:06 PM
0 · Reply
JussieLivermore
JussieLivermore Mar. 12 at 1:50 AM
$IRD Because some of the old timers on this board know that I have been around a long time, done well on this stock and am mostly a stock trader, they have messaged me about advice on holding/selling. Here is what I do in general with all my positions, illustrated using IRD. Look at the price marked $2.28, the weekly candle went down below the prior week, I would reduce/sell. However, once it reclaimed $2.28 I would buy back. Notice same thing happened on the marked $3.32 level. The daily volume is now high enough to do this with most sized accounts. For me right now, I am no longer trading IRD, I am holding a position of 70k shares for long term, banked a nice profit and if the stock goes to $0 will still end up with a very nice gain. Good luck.
0 · Reply
ifinitis
ifinitis Mar. 11 at 7:35 PM
$IRD Looking good! We need to break and hold above $5.20, then we most likely test 3 year high of $6.60. Above $6.60, next test IMO is $9.80/$10 which is the 5 year high area. Squeeze on good trial news, etc, could accelerate and extend move. Protect your Principal. Trade wisely!
0 · Reply
signaljumper
signaljumper Mar. 10 at 4:58 PM
$IRD ready for the big Fonds ? Large asset managers such as: Vanguard Group BlackRock Fidelity Investments often have internal policies like: “Only stocks above $5” “Minimum market capitalization requirements” “Minimum liquidity standards”
1 · Reply
Atime2Buy
Atime2Buy Mar. 10 at 3:42 PM
$IRD moving on up
0 · Reply
Um8a123
Um8a123 Mar. 10 at 3:03 PM
0 · Reply
grobbma
grobbma Mar. 10 at 3:02 PM
$IRD Watch out for dilutive stock offering.
1 · Reply
ProfitAssassin
ProfitAssassin Mar. 10 at 2:59 PM
$IRD I’m very ok to see the 7 today
0 · Reply
TruthTooPower
TruthTooPower Mar. 10 at 2:55 PM
$IRD!!! Boys Double Digits Not A Doubt!!!
0 · Reply
Atime2Buy
Atime2Buy Mar. 10 at 2:52 PM
$IRD cow
0 · Reply
signaljumper
signaljumper Mar. 10 at 2:03 PM
$IRD lets See If WE can Close above 5 bucks today. My target If ph2 are good and heading to pdufa Data in Oktober i Set my target at around 12 to 16 bucks
0 · Reply
dixiebull
dixiebull Mar. 10 at 1:21 PM
$IRD hit 5 yesterday
0 · Reply